Contract VA797P15A0019
Regeneron Pharmaceuticals Inc · Department Of Veterans Affairs · August 26, 2015
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on August 26, 2015 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ V797D50416. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 31, 2019. If all options are exercised, the contract could reach $3.75 million.
Contract details
- PIID
- VA797P15A0019
- Parent IDIQ
- V797D50416
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- August 26, 2015
- Latest action
- December 31, 2019
Description
2020 PUBLIC LAW UPDATES
Modification timeline
-
December 31, 2019Mod P00009$0
-
July 22, 2019Mod P00008EXERCISE 4TH AND FINAL OPTION YEAR ON BPA FOR ARCALYST$0
-
December 20, 2018Mod P000072019 PUBLIC LAW UPDATES$0
-
August 26, 2018Mod P00006EXERCISE THE OPTION YEAR$0
-
December 13, 2017Mod P000052018 PUBLIC LAW UPDATES.$0
-
August 21, 2017Mod P00004BPA EXTENSION FOR VA797P-15-A-0019 FOR ARCALYST$0
-
December 28, 2016Mod P000032017 PL UPDATES$0
-
September 12, 2016Mod P00002OPTION YEAR 1$0
-
December 22, 2015Mod P000012016 PL UPDATES$0
-
August 26, 2015Base awardSPECIALTY BPA - ARCALYST$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract VA797P15A0019?
Contract VA797P15A0019 is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Veterans Affairs on August 26, 2015 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 9 times since the base award.
Who won contract VA797P15A0019?
Regeneron Pharmaceuticals Inc won contract VA797P15A0019 from Department Of Veterans Affairs.
How much is contract VA797P15A0019 worth?
Contract VA797P15A0019 has obligated $0 to date but carries a potential ceiling of $3.75 million if fully funded and all options are exercised.